Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Molecular epidemiology.

P Boffetta1

  • 1Unit of Environmental Cancer Epidemiology, International Agency for Research on Cancer, Lyon, France. boffetta@iarc.fr

Journal of Internal Medicine
|January 13, 2001
PubMed
Summary
This summary is machine-generated.

Biomarkers enhance epidemiology, but molecular epidemiology studies require rigorous design and analysis. Their added value must be systematically assessed, with validation and careful consideration of bias and confounding factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European cancer mortality predictions for the year 2026: the levelling of female lung cancer mortality.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

European cancer mortality predictions for the year 2025 with focus on breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Occupational benzene exposure and skin cancers: a systematic review and meta-analysis.

Occupational medicine (Oxford, England)·2025
Same author

Strong inorganic acid mists and respiratory tract cancers: a meta-analysis.

Occupational medicine (Oxford, England)·2025
Same author

Gastrointestinal cancer and occupational diesel exhaust exposure: a meta-analysis of cohort studies.

Occupational medicine (Oxford, England)·2024
Same author

Long-term exposure to particulate matter and all-cause and cause-specific mortality in an analysis of multiple Asian cohorts.

Environment international·2024
Same journal

Patients with hereditary hemorrhagic telangiectasia have significantly reduced overall survival-And likely by a greater magnitude than we realize.

Journal of internal medicine·2026
Same journal

Social jet lag is associated with incident cardiovascular disease independent of sleep duration and cardiac genetic risk.

Journal of internal medicine·2026
Same journal

Multicenter validation of a severity index model for predicting postoperative acute kidney injury.

Journal of internal medicine·2026
Same journal

The changing epidemiology of human type 2 diabetes-associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities.

Journal of internal medicine·2026
Same journal

Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humans.

Journal of internal medicine·2026
Same journal

Authors' reply: Myasthenia gravis following the initiation of statin therapy.

Journal of internal medicine·2026
See all related articles

Area of Science:

  • Epidemiology
  • Molecular Biology
  • Genetics

Background:

  • Biomarker use in epidemiology is established but expanding due to advances in molecular biology and genetics.
  • Molecular epidemiology, utilizing biomarkers, faces similar design and analysis challenges as traditional epidemiological studies.

Purpose of the Study:

  • To highlight the opportunities presented by biomarkers in epidemiology.
  • To emphasize the need for systematic assessment of the added value of biomarkers over traditional methods.
  • To underscore the importance of rigorous validation, bias, and confounding control in molecular epidemiology.

Main Methods:

  • Review of existing epidemiological study designs.
  • Analysis of challenges in molecular epidemiology.

Related Experiment Videos

  • Discussion of biomarker validation and bias assessment.

    • Main Results:

    • Biomarkers offer new avenues for epidemiological research.
    • Molecular epidemiology shares methodological rigor requirements with traditional epidemiology.
    • Systematic validation and bias control are crucial for biomarker utility.

    Conclusions:

    • Biomarkers significantly expand epidemiological research capabilities.
    • Molecular epidemiology demands stringent study design, validation, and analysis.
    • The added value of biomarkers must be critically evaluated to ensure reliable epidemiological insights.